Li Med Pharma Private Limited
About Li Med Pharma Private Limited
Data last updated:
Li Med Pharma Private Limited is a private limited company based in Thiruvananthapuram, Kerala, India. It operates in the healthcare services segment of the healthcare sector. It was incorporated on 28 July 2022.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U85100KL2022PTC077096.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Shafi Puzhakkarayil Ayush and Gopalakrishnapillai Anish.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ushus Ward 4 House No. 617G Andoor Enikkara Karakulam P.O., Thiruvananthapuram, Kerala, India – 695564.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.84 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹23.04 Lakh (net margin 6%) and EBITDA of ₹32.48 Lakh (EBITDA margin 8.5%).
The company has about 41 employees on its provident fund (EPFO) records.
Company details
Contact details
Li Med Pharma Private Limited's registered office is in Thiruvananthapuram, Kerala.
- Registered AddressUshus Ward 4 House No. 617G Andoor Enikkara Karakulam P.O., Thiruvananthapuram, Kerala, India – 695564
- IndustryHealthcare, Human Health Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Li Med Pharma is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Li Med Pharma Private Limited, buy the company report.
Financials of Li Med Pharma Private Limited
FY 2025 filings availableLi Med Pharma Private Limited reported revenue of ₹3.84 Cr (up 18% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 18% in the latest year. EBITDA rose 12% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹32.48 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹23.04 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 8.5% | ||
| Net Profit Margin | 6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Li Med Pharma Private Limited, buy the company report.
Board of directors of Li Med Pharma Private Limited
Li Med Pharma has 5 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shafi Puzhakkarayil Ayush Also directs: Li Med Labs Private Limited | Director | 28 Jul 2022 | 4 Years 3 Months | Current |
| Gopalakrishnapillai Anish Also directs: Li Med Labs Private Limited, Penta Holidays Private Limited | Director | 28 Jul 2022 | 4 Years 3 Months | Current |
| Ramanath Iyer Ganesh Also directs: Li Med Labs Private Limited | Director | 28 Jul 2022 | 4 Years 3 Months | Current |
| Musthafa Shafeek Ibrahim Also directs: Li Med Labs Private Limited | Director | 28 Jul 2022 | 4 Years 3 Months | Current |
| Mithun Anver Also directs: Li Med Labs Private Limited | Director | 28 Jul 2022 | 4 Years 3 Months | Current |
Peer comparison
Li Med Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (human health activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dr. Trivedi's Total Health Care Private Limited | ₹3.87 Cr (FY 2024) | 15.0% | Mumbai, Maharashtra, India | |||
| Crystal Clinic and Hospitals Private Limited | ₹3.87 Cr (FY 2025) | 449.0% | Gurgaon, Haryana, India | |||
| C3 Medicare Private Limited | ₹3.86 Cr (FY 2025) | 117.0% | Mumbai, Maharashtra, India | |||
| Ikigai Services Private Limited | ₹3.86 Cr (FY 2025) | 892.0% | Mumbai, Maharashtra, India | |||
| Vardhman Diagnostics Private Limited | ₹3.86 Cr (FY 2024) | 2.0% | New Delhi, Delhi, India | |||
| Li Med Pharma Private Limitedthis company | ₹3.84 Cr (FY 2025) | ₹23.04 Lakh | 6% | 18.0% | Thiruvananthapuram, Kerala, India | |
| Sishya Meditech Private Limited | ₹3.84 Cr (FY 2025) | 29.0% | Chennai, Tamil Nadu, India | |||
| Tavernier Trading Private Limited | ₹3.84 Cr (FY 2025) | 109161.0% | Mumbai, Maharashtra, India | |||
| Jagdhan Health Care Private Limited | ₹3.83 Cr (FY 2024) | -8.0% | Howrah, West Bengal, India | |||
| Thalamus Institute of Medical Sciences Private Limited | ₹3.83 Cr (FY 2024) | 1490.0% | Siliguri, West Bengal, India | |||
| Elite RCM Private Limited | ₹3.83 Cr (FY 2025) | 59.0% | Dehradun, Uttarakhand, India |
To see the full peer comparison of Li Med Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Li Med Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Li Med Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Li Med Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Li Med Pharma Private Limited has 5 board changes on record since 2022: 5 appointments. The latest: Gopalakrishnapillai Anish was appointed as Director on 28 Jul 2022.
Frequently asked questions
Li Med Pharma is an active private limited company based in Thiruvananthapuram, Kerala, India. The company works in human health activities, within the healthcare industry. It was incorporated on 28 July 2022 (4+ years old) and is registered under CIN U85100KL2022PTC077096.
Li Med Pharma has 5 current directors:
- Shafi Puzhakkarayil Ayush - Director
- Gopalakrishnapillai Anish - Director
- Ramanath Iyer Ganesh - Director
- Musthafa Shafeek Ibrahim - Director
- Mithun Anver - Director
The latest financial statements of Li Med Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Li Med Pharma is U85100KL2022PTC077096. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Li Med Pharma was incorporated on 28 July 2022, making it 4+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Li Med Pharma by revenue are Dr. Trivedi's Total Health Care Private Limited, Crystal Clinic and Hospitals Private Limited, C3 Medicare Private Limited, Ikigai Services Private Limited, Vardhman Diagnostics Private Limited and 5 more, all in the same principal business activity (human health activities).
Gopalakrishnapillai Anish was appointed as Director on 28 Jul 2022. Mithun Anver was appointed as Director on 28 Jul 2022. Musthafa Shafeek Ibrahim was appointed as Director on 28 Jul 2022. Li Med Pharma has 5 board changes on record in total.
The registered office of Li Med Pharma is at Ushus Ward 4 House No. 617G Andoor Enikkara Karakulam P.O., Thiruvananthapuram, Kerala, India – 695564.
Li Med Pharma operates in the healthcare industry, in the human health activities segment.
Li Med Pharma can be reached at its registered office: Ushus Ward 4 House No. 617G Andoor Enikkara Karakulam P.O, Thiruvananthapuram, Kerala, India – 695564.
Li Med Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Ernakulam.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
